CLINICAL_TRIALS
trial_result
· 2023-07-19
Clinical Trial Update: Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo [Phase 3]
Summary
A Phase 3 trial assessing long-term efficacy and safety of topical ruxolitinib cream for vitiligo has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Incyte Corporation | Conditions: Vitiligo | Phase 3 | Status: COMPLETED | Results posted: 2023-07-19